middle.news
Imagion Biosystems Secures $2.85M to Propel Cancer Imaging Trials
11:31am on Monday 29th of September, 2025 AEST
•
Healthcare
Read Story
Imagion Biosystems Secures $2.85M to Propel Cancer Imaging Trials
11:31am on Monday 29th of September, 2025 AEST
Key Points
Settlement of Tranche 2 placement raising $2.85 million
Issuance of 188 million new shares and 233 million listed options
Funds earmarked for HER2 Breast Cancer Phase 2 trial and other cancer studies
Key milestones include FDA IND submission and new intellectual property filings
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imagion Biosystems (ASX:IBX)
OPEN ARTICLE